A physicians’ group has recommended new guidelines that doctors treat women who have osteoporosis with bisphosphonates (alendronate, risedronate, or zoledronic acid) or denosumab, a biologic agent. The new guidelines, from the American College of Physicians (ACP), were published in the Annals of Internal Medicine, according to a news release from the ACP. ACP’s previous recommendations… Continue reading New Guidelines for Treating Osteoporosis